Literature DB >> 11606587

Presenilin 1 independently regulates beta-catenin stability and transcriptional activity.

R Killick1, C C Pollard, A A Asuni, A K Mudher, J C Richardson, H T Rupniak, P W Sheppard, I M Varndell, J P Brion, A I Levey, O A Levy, M Vestling, R Cowburn, S Lovestone, B H Anderton.   

Abstract

Presenilin 1 (PS1) regulates beta-catenin stability; however, published data regarding the direction of the effect are contradictory. We examined the effects of wild-type and mutant forms of PS1 on the membrane, cytoplasmic, nuclear, and signaling pools of endogenous and exogenous beta-catenin by immunofluorescence microscopy, subcellular fractionation, and in a transcription assay. We found that PS1 destabilizes the cytoplasmic and nuclear pools of beta-catenin when stabilized by Wnt or Dvl but not when stabilized at lower levels of the Wnt pathway. The PS1 mutants examined were less able to reduce the stability of beta-catenin. PS1 also inhibited the transcriptional activity of endogenous beta-catenin, and the PS1 mutants were again less inhibitory at the level of Dvl but showed a different pattern of inhibition toward transcription below Dvl. The transcriptional activity of exogenously expressed wild-type beta-catenin and two mutants, DeltaN89beta-catenin and DeltaSTbeta-catenin, were also inhibited by wild-type and mutant PS1. We conclude that PS1 negatively regulates the stability and transcriptional activity of beta-catenin at different levels in the Wnt pathway, that the effect on transcriptional activity appears to be independent of the GSK-3beta mediated degradation of beta-catenin, and that mutations in PS1 differentially affect the stability and transcriptional activity of beta-catenin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606587     DOI: 10.1074/jbc.M108332200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism.

Authors:  Jie Shen; Raymond J Kelleher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-29       Impact factor: 11.205

2.  Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation.

Authors:  Jia-Ling Teo; Hong Ma; Cu Nguyen; Crystal Lam; Michael Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-10       Impact factor: 11.205

Review 3.  Similarities and differences between the Wnt and reelin pathways in the forming brain.

Authors:  Orly Reiner; Tamar Sapir
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 4.  The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.

Authors:  Sally Hunter; Thomas Arendt; Carol Brayne
Journal:  Mol Neurobiol       Date:  2013-04-03       Impact factor: 5.590

Review 5.  Presenilin: RIP and beyond.

Authors:  Matthew R Hass; Chihiro Sato; Raphael Kopan; Guojun Zhao
Journal:  Semin Cell Dev Biol       Date:  2008-11-27       Impact factor: 7.727

Review 6.  The way Wnt works: components and mechanism.

Authors:  Kenyi Saito-Diaz; Tony W Chen; Xiaoxi Wang; Curtis A Thorne; Heather A Wallace; Andrea Page-McCaw; Ethan Lee
Journal:  Growth Factors       Date:  2012-12-21       Impact factor: 2.511

7.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

8.  The presenilin-1 ΔE9 mutation results in reduced γ-secretase activity, but not total loss of PS1 function, in isogenic human stem cells.

Authors:  Grace Woodruff; Jessica E Young; Fernando J Martinez; Floyd Buen; Athurva Gore; Jennifer Kinaga; Zhe Li; Shauna H Yuan; Kun Zhang; Lawrence S B Goldstein
Journal:  Cell Rep       Date:  2013-11-14       Impact factor: 9.423

9.  Alterations of beta-catenin pathway in non-melanoma skin tumors: loss of alpha-ABC nuclear reactivity correlates with the presence of beta-catenin gene mutation.

Authors:  Claudio Doglioni; Sara Piccinin; Silvia Demontis; Maria Giulia Cangi; Lorenza Pecciarini; Concetta Chiarelli; Michela Armellin; Tamara Vukosavljevic; Mauro Boiocchi; Roberta Maestro
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

10.  A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signaling.

Authors:  Hirochika Kitagawa; William J Ray; Helmut Glantschnig; Pascale V Nantermet; Yuanjiang Yu; Chih-Tai Leu; Shun-ichi Harada; Shigeaki Kato; Leonard P Freedman
Journal:  Mol Cell Biol       Date:  2007-08-20       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.